期刊文献+

2型糖尿病并非酒精性脂肪性肝病患者炎症反应及氧化应激水平与动脉硬化的关系 被引量:4

The correlation of inflammation and oxidative stress with atherosclerosis in patients of type 2 diabetes mellitus with nonalcoholic fatty liver disease
下载PDF
导出
摘要 目的了解2型糖尿病合并非酒精性脂肪性肝病患者体内炎症反应、氧化应激水平及其与颈动脉内膜中层厚度(IMT)的相关性。方法选取2型糖尿病患者158例,按照是否合并非酒精性脂肪性肝病分为合并脂肪肝组(76例)和单纯糖尿病组(82例)。检测体重指数(BMI)、血压、空腹血糖(FPG)、糖化血红蛋白(HbA1c)、空腹胰岛素(FINS)、血脂、丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、白细胞介素(IL)-6、高敏C反应蛋白(hs—CRP)、8-异前列腺素F2d(8-iso—PGF20t)及颈动脉内膜中层厚度。结果合并脂肪肝组患者BMI、三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL—C)、丙氨酸氨基转移酶(ALT)、IL-6、8-iso—PGF2α、hs—CRP、胰岛素抵抗指数(HOMA—IR)及IMT水平高于单纯糖尿病组,而HDL—C则低于单纯糖尿病组(P〈0.05)。IMT与IL-6、8-iso—PGF2α、hs—CRP、HOMA—IR、LDL-C呈正相关(P〈0.01)。多元逐步回归分析显示,IL-6、8-iso-PGF2α、hs—CRP是颈动脉IMT的主要危险因素。结论非酒精性脂肪性肝病加重2型糖尿病患者炎症反应和氧化应激,炎症反应和氧化应激可能是动脉硬化的主要危险因素。 Objective To investigate the correlation of inflammation and oxidative stress with carotid artery intima-media thickness(IMT) in type-2 diabetes mellitus(type-2 DM) patients with nonalcoholic fatty liver disease(NAFLD). Methods 185 patients with type-2 DM were divided into two groups, DM with NAFLD group(n =76) and DM without NAFLD group(n =82). The levels of BMI,blood pressure ,fasting plasma glucose (FPG), HbAlc ,fasting insulin( FINS), serum lipids, aminopherase, serum interleukin-6 (IL-6), hs-CRP,8-iso-PGF2ct and carotid artery IMT were measured in all subjects. Results The levels of BMI, TG, TC, LDL-c, ALT, IL-6,8-iso-PGF2α, hs-CRP, insulin resistance index ( HOMA-IR ) and IMT in DM with NAFLD group were significantly higher than those in DM without NAFLD group(P 〈 . 05 ), whereas the level of HDL-C was otherwise( P 〈 0.05 ). The carotid artery IMT was positively relat- ed with IL-6,8-iso-PGF2α, hs-CRP, HOMA-IR and LDL-C ( P 〈 0. 05 ). A tstepwise muhiple linear regres- sion analysis showed that IL-6,8-iso-PGF2α and hs-CRP were major risk factors of carotid artery IMT. Conclusion NAFLD can increase the degree of inflammation and oxidative stress in patients with type-2 DM,which were major risk factors for atherosclerosis.
作者 邱宇珍 龙辉
出处 《临床内科杂志》 CAS 2013年第2期89-91,共3页 Journal of Clinical Internal Medicine
关键词 2型糖尿病 非酒精性脂肪性肝病 炎症反应 8-异前列腺素F2Α 颈动脉内膜中层厚度 Type 2 diabetes mellitus Nonalcoholic fatty liver disease Inflammation 8-iso-PGF2α Carotid artery intima-media thickness
  • 相关文献

参考文献4

二级参考文献10

共引文献596

同被引文献49

  • 1牟建军.盐与高血压研究进展[J].中国医学前沿杂志(电子版),2011,3(2):22-25. 被引量:21
  • 2中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中华糖尿病杂志,2010,2(1). 被引量:529
  • 3Choi SW, Lee YH, Kweon SS, et al. Association between total bilirubin and hemoglobin AI c in Korean type 2 diabetic patients. J Korean Med Sci ,2012,27 : 1196-1201.
  • 4Jo J, Yun JE, Lee H, et al. Total, direct, and indirect serum bilirubin concentrations and metabolic syndrome among the Korean population. Endocrine,2011,39 : 182-189,.
  • 5Hart SS, Na KY, Chae DW, et al. High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy. To- hoku J Exp Med,2010,221:133-140.
  • 6Vftek L. The role of bilirubin in diabetes, metabolic syndrome, and car- diovascular diseases. Front Pharmacol ,2012,3 : 55.
  • 7王瑞良,张洪梅,苏青.糖脉康颗粒对糖尿病大鼠肾组织氧化应激及羰基应激的影响.中国医师杂志,2011,z2:7-10.
  • 8Lanone S, Bloc S, Foresti R, et al. Bilirubin decreases NOS2 expression via inhibition of NAD (P) H oxidase : implications for protection against endotoxic shock in rats. FASEB J,2005,19 : 1890-1892.
  • 9Baranano DE, Rao M, Ferris CO, et al. Biliverdin reductase : A major physiologic cytoprotectant. Proc Natl Acad Sci ,2002,99:16093-16098.
  • 10Sedlak TW, Snyder SH. Bilirubin benefits:cellular protection by a bili- verdin reductase antioxidant cycle. Pediatrlcs,2004,113 : 1776-1782.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部